The most fundamental characteristics of a child are growth and development. Under normal circumstances growth follows a pattern that can be predicted. As a pediatrician we have to distinguish between normal and abnormal growth and recognize a normal variation from a pathological condition. Thorough height measurements performed every 6 months and plotted on the reference growth curve is the simplest and low-cost tool to detect an abnormal growth. Simple guideline is proposed to manage a child with short stature.
General health of a child is indicated by his or her growth pattern. As a pediatrician we have to distinguish between normal and abnormal growth. We have to recognize a normal variation from a pathological condition based on medical history, growth chart, and physical examination, including body proportions and dysmorphic features. Thorough height measurements performed every 6 months and plotted on the reference growth curve is the most simple and low cost tool to recognize an abnormal growth pattern. The most important factor in evaluating growth of a child is height compared to target height. 2 Growth impairment in children is indicated by some terms. Failure to thrive is defined as weight for age that falls below the 5th percentile on multiple occasions or weight deceleration that crosses two major percentile lines on a growth chart in the first years of life. Failure to thrive should not be confused with short stature or growth retardation. Failure to thrive is associated with greater impairment in weight gain than linear growth (resulting in a reduced weight-for-height ratio). Although failure to thrive may be associated with short stature or slow growth velocity, it primarily represents an inability to gain weight appropriately and only secondarily an impairment in linear growth. 2 Short stature is defined as height less than -2 standard deviation (SD) or less than 2.3 rd (about 3 rd ) percentile for a given age, sex and reference population. 3, 4 Great variation of congenital or acquired conditions, such as Growth Hormone Deficiency (GHD), syndromes, skeletal dysplasias, can be a cause of growth failure in industrialized countries. Meanwhile, in developing countries the major problem is malnutrition. However, other causes have to be considered hence early diagnosis and treatment of these conditions is important to prevent further health damage, to optimize adult height and increase quality of life.
Normal Growth
A complex interaction among genetic, nutritional, and hormonal factors in a cellular environment conducive for growth produces normal somatic growth. To investigate the causes of growth impairment, it is important to understand the fundamental elements of normal growth, including nutrition, oxygen, hormones, the absence of toxins, and the more general components of a healthy environment for children, including adequate sleep, exercise, and psychosocial factors. Hormonal factors, in particular, are required in the right amounts and at the right times for optimal growth. Growth hormone (GH) and insulin-like growth factor-I (IGF-I) play key roles in this process. Other hormones (e.g., thyroid hormone, insulin, sex steroids, and glucocorticoids) also affect growth, in part through their interactions with the hypothalamic-pituitary-GH-IGF axis. 2, 5 Intrauterine growth Growth of a fetus starts with a single fertilized cell and ends with differentiation into more than 200 cell types, length increasing by 5000-fold, surface area by 6x106-fold, and weight by 6x1012-fold. Generally, the growth of the fetus depends on the availability of adequate oxygen and nutrition, regulated by growth factors, and supervised by an elementary genetic plan. Genetic factors are more important prior in gestation, whereas the maternal environment achieves more importance late in gestation. 6 
Maternal factors
Maternal factors can contribute to intrauterine growth retardation, including uterine environment such as tumors or malformations, chronic disease, chronic ingestion of alcohol or certain medications, smoking, infections as toxoplasmosis, rubella, cytomegalovirus, herpes simplex and HIV. In addition, multiple births may cause poor fetal growth. 7 Maternal height is related to birth size. 8 
Placental factors
The placenta supplies the adequate nutrition and oxygen and regulates hormones including growth factors such as growth hormone variant, human placental lactogen and organ-specific hormones such as corticotropin-releasing hormone (CRH), hepatic and epidermal growth factors. Placental size and birth weight are positively correlated in many species. In early to mid-pregnancy, insults such as inappropriate maternal nutrition, oxygen and thermal stress can significantly disrupt placental development and subsequent fetal growth. 1, 6 
Fetal factors
Insulin is released by the fetal pancreas as a response of nutrient reserve and is the one of the most important intrauterine growth factors. Insulin-like growth factors (IGF) are produced by fetus, of which IGF-2 prevails and modifies the growth factor actions with particular binding proteins (IGFBP). Interestingly the intra uterine production of IGF-I is independent of growth hormone, in contrast to the GH dependent IGF-I secretion later in life. 5 Although GH and thyroid hormone are of main importance for normal growth in childhood, their role in the control of fetal growth is relatively small, illustrated by the normal birth weight and length in most infants with congenital GH deficiency and hypothyroidism. 5
Postnatal growth
Generally, the peak postnatal growth rate occurs just after birth, and decrease at mid childhood. The stunning acceleration in stature defined as the pubertal growth spurt results in a peak of growth velocity. The final deceleration in growth rate occurs until fusion of the epiphyses of the long bone then growth concludes. 6 
Endocrine factors
Growth hormone (GH) or somatotropin is secreted by the pituitary. The secretion is regulated by different factors. GH production is suppressed by hypothalamic GH release-inhibiting factor (somatostatin) and stimulated by GH-releasing hormone (GHRH). The effect of GH on growth is mostly mediated by IGF-I, however GH also has direct effects such as lipolysis, increased amino acid transport into tissues, and increased protein and glucose synthesis in the liver as well as some direct effects on the epiphyseal growth plate. Secretion of GH is pulsatile; The peaks of GH secretion occur in the night. Higher concentration promptly in neonatal period, decline through childhood, and incline causing increased pulse amplitude (but not frequency) during puberty stimulated by sex steroids. 6 During puberty, an orchestra of sex steroid (testosterone, estrogen), GH, thyroid hormone and nutrition as instruments will accelerate growth rate known as the pubertal growth spurt. However, other factors have to be reminiscing about influence final heights. These factors include genetic, socioeconomic, psychological, physical activity, chronic disease. 6,10,11
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Growth monitoring
Detection of growth disorders begins with implying regular measurements of weight and length/height. Accurate and precise measurement, recording and plotting to the appropriate curves are the simplest and low cost tools. Training in measurements and plotting as well as attention to details are needed to avoid errors and imprecise plotting. 12 The important point of efficient monitoring is the routine practice of measuring, recording and plotting in every office visit at least every 6 months. 4 Head circumference should be measured using a non-stretchable tape, usually as the mean of three measurements to determine the maximum occipito-frontal circumference (OFC). It may also be disproportionately large or small in some growth disorders and can be a hint for further diagnostic. 1, 15 Target Height A child's genetic potential is essential in the evaluation of his/her present growth pattern, and any deviation from the expected height for the family should raise concern. 70-80 % of height is determined by genetic Parents' heights are preferable to be measured rather than estimation or self-reports. The target height obtained by this method is then applied to the 20year line of the gender-appropriate growth chart. 12 In addition to the calculated target height, the predicted final adult height based on the skeletal age could also be considered in the evaluation of the short child. There are three methods for calculating a child's predicted adult height, the Tanner-Whitehouse method, the Roche-Wainer-Thissen method and the Bayley-Pinneau method. However, predictions of final adult height are not very accurate and are of limited value in children with growth disorders, because the methods are based on a normal population. 16, 17 PEDIATRIC ONCALL JOURNAL (APRIL-JUNE 2019) 16 (2) 
Height measurement

Evaluation of a child with short stature
The large number of clinical conditions associated with short stature or growth retardation can make the task of identifying a specific diagnosis particularly challenging. The evaluation of a child with short stature starts with a good medical history. Important clues can be obtained for a diagnosis as illustrated in table 1. Physical examination focuses on specific causes of short stature as summarized in table 2. If medical history and/or physical examination leads to a cause of short stature specific further diagnostic investigations follows. However, in most children that present with short stature the cause is not clear. In a child with proportionate short stature screening of secondary growth disorders (celiac disease, hypothyroidism, GH deficiency) should be performed (table 3) . In disproportionate short stature a primary growth disorder is more likely and can be further investigated by a skeletal survey (table 4) . In specific cases an MRI or genetic evaluation is necessary to find a cause of short stature (table 5) . 1, 19, 20 We propose an algorithm for the evaluation of a child with short stature, based on medical history, physical examination and screening laboratory investigations (Algorithm 1). The European Society of Pediatric Endocrinology (ESPE) has proposed a classification of growth disorders (table 6) .
Indications for GH therapy
Growth hormone deficiency is still the main reason for growth hormone replacement treatment, but nowadays GH is also being used in non-GH deficient syndromes associated with short stature. Aim of GH therapy is to normalize height in short or long term and to achieve better final height. GH is also used to improve body composition, bone density, cardiovascular risk, respiratory function, behavior, socialization and selfesteem in patients with Prader Willi syndrome. 21, 22, 23 Non-endocrine problems of growth Nutritional growth retardation (NGR) is most prevalent in populations at risk of poverty. However in affluent communities patients with NGR are often referred to the specialist because of short stature and delayed sexual development. Patients with NGR do not appear wasted, and the usual biochemical parameters of nutritional status, including serum levels of retinolbinding protein, pre-albumin, albumin, transferrin, and triiodothyronine (T3) levels, do not differentiate 
Suggested investigation Interpretation
Bone survey: Table 5 . Specific investigations in a child with short stature 19, 20 
MRI Visualization of hypothalamus, pituitary
Growth hormone (GH) provocation test Growth hormone deficiency Indicated genetic analyses Genetic disorders Genetic defects in one of the components (pituitary GH secretion, GH receptor (GHR), postreceptor signaling and IGF-I) NGR patients from those with familial or constitutional short stature. The explanation is that NGR patients have adjusted to their suboptimal nutritional intake and they maintain homeostasis by decelerating growth, thereby reaching equilibrium with continuity of biochemical nutritional markers and genetic growth potential. Deceleration of growth creates the nutrient demands into balance with the nutritional intake, without adversely affecting biochemical or functional homeostatic measures. 12, 24 The high prevalence of infections in developing countries attenuates linear growth of children living in impoverished area. Such infections can decrease linear growth by affecting nutritional status. Whilst infection of cells directly involved in bone remodeling (osteoclasts or osteoblasts) by specific viruses may also directly affect linear growth. Acute or chronic inflammation may modulate long bone growth via induction of IL-6 production. Induction of the acute phase response and production of proinflammatory cytokines such as TNF-α, IL-1β and IL-6 may directly affect the process of bone remodelling that is required for long bone growth. TNFα could lead to increased production of macrophages and diminished production of osteoclasts. 25 
Short
Conclusion
The management of a child with short stature is a challenge for every pediatrician. In this article we have given an overview over the process of normal intrauterine and postnatal growth. We highlighted the importance of adequate measurement of height and body proportions in order to distinguish primary and secondary growth disorders. Medical history and physical examination is essential in the evaluation of a child of short stature. We have proposed a guideline that can be used in the management of a child with short stature.
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